摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5'-O-(N-(2-benzyloxybenzoyl)sulfamoyl)-3'-O-tert-butyldimethylsilyl-2'-deoxyadenosine 1,8-diazabicyclo[5.4.0]undec-7-ene salt

中文名称
——
中文别名
——
英文名称
5'-O-(N-(2-benzyloxybenzoyl)sulfamoyl)-3'-O-tert-butyldimethylsilyl-2'-deoxyadenosine 1,8-diazabicyclo[5.4.0]undec-7-ene salt
英文别名
[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-[tert-butyl(dimethyl)silyl]oxyoxolan-2-yl]methyl N-(2-phenylmethoxybenzoyl)sulfamate;2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine
5'-O-(N-(2-benzyloxybenzoyl)sulfamoyl)-3'-O-tert-butyldimethylsilyl-2'-deoxyadenosine 1,8-diazabicyclo[5.4.0]undec-7-ene salt化学式
CAS
——
化学式
C9H16N2*C30H38N6O7SSi
mdl
——
分子量
807.059
InChiKey
AMFBOFDOJBOLSG-UTXSYOJYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.02
  • 重原子数:
    56
  • 可旋转键数:
    12
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.51
  • 拓扑面积:
    194
  • 氢给体数:
    2
  • 氢受体数:
    12

反应信息

  • 作为反应物:
    描述:
    5'-O-(N-(2-benzyloxybenzoyl)sulfamoyl)-3'-O-tert-butyldimethylsilyl-2'-deoxyadenosine 1,8-diazabicyclo[5.4.0]undec-7-ene salt 在 palladium on activated charcoal 氢气 作用下, 以 甲醇 为溶剂, 反应 8.0h, 生成
    参考文献:
    名称:
    Antitubercular Nucleosides That Inhibit Siderophore Biosynthesis:  SAR of the Glycosyl Domain
    摘要:
    Tuberculosis is the leading cause of infectious disease mortality in the world by a bacterial pathogen. We previously demonstrated that a bisubstrate inhibitor of the adenylation enzyme MbtA, which is responsible for the second step of mycobactin biosynthesis, exhibited potent antitubercular activity. Here we systematically investigate the structure-activity relationships of the bisubstrate inhibitor glycosyl domain resulting in the identification of a carbocyclic analogue that possesses a K-I(app) value of 2.3 nM and MIC99 values of 1.56 mu M against M. tuberculosis H37Rv. The SAR data suggest the intriguing possibility that the bisubstrate inhibitors utilize a transporter for entry across the mycobacterial cell envelope. Additionally, we report improved conditions for the expression of MbtA and biochemical analysis, demonstrating that MbtA follows a random sequential enzyme mechanism for the adenylation half-reaction.
    DOI:
    10.1021/jm061068d
  • 作为产物:
    参考文献:
    名称:
    Antitubercular Nucleosides That Inhibit Siderophore Biosynthesis:  SAR of the Glycosyl Domain
    摘要:
    Tuberculosis is the leading cause of infectious disease mortality in the world by a bacterial pathogen. We previously demonstrated that a bisubstrate inhibitor of the adenylation enzyme MbtA, which is responsible for the second step of mycobactin biosynthesis, exhibited potent antitubercular activity. Here we systematically investigate the structure-activity relationships of the bisubstrate inhibitor glycosyl domain resulting in the identification of a carbocyclic analogue that possesses a K-I(app) value of 2.3 nM and MIC99 values of 1.56 mu M against M. tuberculosis H37Rv. The SAR data suggest the intriguing possibility that the bisubstrate inhibitors utilize a transporter for entry across the mycobacterial cell envelope. Additionally, we report improved conditions for the expression of MbtA and biochemical analysis, demonstrating that MbtA follows a random sequential enzyme mechanism for the adenylation half-reaction.
    DOI:
    10.1021/jm061068d
点击查看最新优质反应信息

文献信息

  • Antitubercular Nucleosides That Inhibit Siderophore Biosynthesis:  SAR of the Glycosyl Domain
    作者:Ravindranadh V. Somu、Daniel J. Wilson、Eric M. Bennett、Helena I. Boshoff、Laura Celia、Brian J. Beck、Clifton E. Barry、Courtney C. Aldrich
    DOI:10.1021/jm061068d
    日期:2006.12.1
    Tuberculosis is the leading cause of infectious disease mortality in the world by a bacterial pathogen. We previously demonstrated that a bisubstrate inhibitor of the adenylation enzyme MbtA, which is responsible for the second step of mycobactin biosynthesis, exhibited potent antitubercular activity. Here we systematically investigate the structure-activity relationships of the bisubstrate inhibitor glycosyl domain resulting in the identification of a carbocyclic analogue that possesses a K-I(app) value of 2.3 nM and MIC99 values of 1.56 mu M against M. tuberculosis H37Rv. The SAR data suggest the intriguing possibility that the bisubstrate inhibitors utilize a transporter for entry across the mycobacterial cell envelope. Additionally, we report improved conditions for the expression of MbtA and biochemical analysis, demonstrating that MbtA follows a random sequential enzyme mechanism for the adenylation half-reaction.
查看更多